Clinical Study

Early Response to Dexamethasone as Prognostic Factor: Result from Indonesian Childhood WK-ALL Protocol in Yogyakarta

Figure 1

The Indonesian WK-ALL-2000 protocol for childhood ALL. Induction and consolidation treatment of standard risk protocol (a). One dose of daunorubicin (Dnr) in induction plus a reinduction treatment was added in high-risk protocol (b). The maintenance treatment was similar between the standard risk and high risk protocols (c). 3A/0A were group of patients who received/did not receive 3 extra doses of L-asparaginase during consolidation treatment.
417941.fig.001a
(a)
417941.fig.001b
(b)
417941.fig.001c
(c)